HMOX1 and non-small cell lung carcinoma: Candidate compounds SB 202190 and Nordihydroguaiaretic acid (NDGA) effectively reactivated ferroptosis by inhibiting HO-1, thereby increasing cisplatin sensitivity.<h4>Conclusion</h4>The Nrf2/HO-1 pathway is a significant contributor to cisplatin resistance in NSCLC.